Bolivia, Plurinational State of vs Israel: Hepatitis B surface antigen (HBsAg) prevalence
Bolivia, Plurinational State of
0.1%
in 2024
Israel
0.1%
in 2024
Bolivia, Plurinational State of rank
101st
Israel rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bolivia, Plurinational State of
- Israel
How they compare
Bolivia, Plurinational State of currently reports 0.1% against 0.1% in Israel, a difference of 0.0%.
Across all 10 years both countries report, Israel has been ahead every year.
Bolivia, Plurinational State of ranks 101st and Israel ranks 101st of 194 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.3% | 0.3% | Israel |
| 2020s | 0.1% | 0.1% | 0.0% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bolivia, Plurinational State of or Israel?
- Bolivia, Plurinational State of, at 0.1% against 0.1% in Israel as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bolivia, Plurinational State of and Israel?
- 0.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Israel?
- 10 years are reported by both, from 2015 to 2024.
- How do Bolivia, Plurinational State of and Israel rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bolivia, Plurinational State of ranks 101st and Israel ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.